## SLAB: Silicon Laboratories Inc. - XLK: Technology

### Executive Summary

PARABOLIC warning: MRS_10 at 7.4% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($129.52)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Earnings Estimates Moving Higher for Silicon Labs (SLAB): Time to Buy?**
- Source: Finviz | 20251204T122000 | Bullish | Relevance: 100%
- Earnings estimates for Silicon Laboratories (SLAB) have shown significant improvement, with analysts' growing optimism driving consensus estimates higher for both the next quarter and the full year. The stock currently holds a Zacks Rank #2 (Buy), and its shares have gained 6.3% recently, suggesting investor confidence in its earnings growth prospects. Investors might consider adding SLAB to their portfolios to capitalize on the favorable revisions.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($0.02M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- FMR, LLC: 15.0% (+0.8%)
- Blackrock Inc.: 13.7% (+2.5%)
- Vanguard Group Inc: 11.8% (+1.9%)
- State Street Corpora: 4.7% (+2.4%)
- Macquarie Group Limi: 3.0% (-8.6%)

### Key Risks

1. Valuation stretched: PEG 3.0x requires aggressive growth execution.
2. Elevated short interest (9.4%): bears positioning against stock.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Momentum building: MRS_10 improving +4.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.03 signals overvaluation risk, limited margin of safety. Forward P/E 51.6x attractive for 197% earnings growth. Balance sheet: strong liquidity (4.5x), low leverage (D/E 0.17). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.4B |
| Beta | 1.56 |
| 52W Range | $82.82 - $160.00 |
| Short Interest | 9.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.03 |
| Forward P/E | 51.6 |
| Current P/E | 153.2 |
| YoY Growth | 197.1% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from 2.7% to 7.4% (+4.7% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (7.4% > 6.0%), caution on chasing. MRS_5 at 4.7% confirms short-term momentum alignment. Outperforming sector by 7.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.23), confirming momentum. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 7.36% (CS: 94) | Strong |
| RSI_14 | 66.5 | Neutral |
| MACD Histogram | 2.23 | Bullish |
| vs SMA20 | 1.107x | Above |
| vs SMA50 | 1.071x | Above |
| vs SMA200 | 1.080x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $138.74
- **Stop Loss:** $129.52 (6.6% risk)
- **Target:** $147.96 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 108
- **Position Value:** $14,983.92
- **Portfolio %:** 14.98%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-03 (Est: $0.55)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.31 | $0.32 | +4.2% |
| 2025Q2 | $0.09 | $0.11 | +18.7% |
| 2025Q1 | $-0.09 | $-0.08 | +10.9% |
| 2024Q4 | $-0.11 | $-0.11 | -1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*